Neurotransmitter systems III: Monoamines Flashcards
What are the central nervous systems which controls behaviour?
Autonomic Nervous System
Hypothalamic-Pituitary Neurohormones
Diffuse Monoamine Modulatory System
What are the Diffuse monoamine modulatory systems?
4 monoamine modulatory systems:
- Noradrenaline: Noradrenergic Locus Coeruleus
- Serotonin (5-HT): Serotonergic Raphe Nuclei
- Dopamine: Dopaminergic Substantia Nigra and Ventral Tegmental Area
- Acetylcholine: Cholinergic Basal Forebrain and Brain Stem Complexes
What do the 4 diffuse modulatory systems have in common?
Ø Released from neurones which arise from brain stem
Ø Neurones project from central core where cell bodies are located to many different regions of the brain where the neurotransmitter gets released
Ø One neurone influences many others
Ø Synapses release transmitter molecules into extracellular fluid
What type of receptors are monoamine receptors?
G-protein coupled receptors
Describe the Noradrenergic modulatory pathway.
noradrenergic neurones project from central core called Locus Coerulus to different brain regions (e.g. cortex, amygdala, hypothalamus, cerebellum, spinal cord)
Describe the Action of noradrenaline at synaptic bouton.
1) Noradrenaline gets into synaptic vesicles
2) Noradrenaline released upon stimulation by action potential
3) Noradrenaline binds to post-synaptic noradrenergic receptors (G-coupled) to carry on the message
4) Noradrenaline also activates pre-synaptic auto-receptors (a2 receptors) which act via a negative feedback mechanism and inhibit the release of noradrenaline
What are the Effects of increased noradrenaline?
- Cardiovascular effects (tachycardia, high blood pressure)
- Addictive-like behaviour (gambling)
- Hyperarousal
What are the Effects of decreased noradrenaline?
- Depression
- Parkinson’s disease
Describe process of Noradrenaline Regulation: Reuptake mechanism.
noradrenaline transporters on pre-synaptic membrane reuptake excess noradrenaline from synapse
once inside the synapse, noradrenaline is metabolised and broken down by monoamine oxidase (MAO), terminating its action
Describe the structure of Noradrenaline receptors.
G-protein coupled receptors:
- Alpha 1 (Gq)
- Alpha 2 (Gi)- autoreceptors
- Beta (Gs)
What are the Drugs that increase noradrenaline levels?
· Reserpine: depletes noradrenaline stores by inhibiting vesicular uptake
· Amphetamine (indirect sympathomimetic): enters vesicles displacing NA into cytoplasm, increasing NA leakage out of neurone into synapse
· Cocaine: blocks NA reuptake
Describe the Action of drugs in depression treatment.
Drugs to increase noradrenaline:
- block monoamine oxidase (MOA)
- block noradrenaline transporters
- block serotonin transporters
What are the Dopaminergic Modulatory Pathways?
Nigrostriatal Pathway
Mesolimbic Pathway
Mesocortical Pathway
Tubero-hypophyseal Pathway
Describe the Nigrostriatal pathway.
dopaminergic neurones project from substantia nigra (SN), where cell bodies are found, to the striatum where dopamine is released to induce MOVEMENT
*degeneration of these neurones decreasing dopmaine levels in the striatum, causing Parkinson’s disease (suppressed movement)
Describe the Mesolimbic pathway.
dopaminergic neurones project from ventral tegmental area (VTA) to amygdala, hippocampus and nuclear accumbens, where dopamine is released to induce REWARD (e.g. food, sex)
- Abused drugs over-stimulate this pathway, increasing pleasure/reward, leading to addiction
- Hyperactivity of this system causes psychotic episodes in schizophrenics
Describe the Mesocortical pathway.
dopaminergic neurones project from ventral tegmental area (VTA) to the cortex, where dopamine is released
Describe the Tubero-hypophyseal pathway..
dopaminergic neurones project from hyopthalamus to the portal capillary system in the median eminence where dopamine is released, acting as a neurohormone by binding to its receptors in the anterior pituitary and inhibiting release of prolactin
*prolactin responsible for mammary gland enlargement and milk production
Dopamine is involved in…
addiction (gambling) emesis ADHD Schizophrenia (hyperactivity of mesolimbic pathway) Parkinson's disease (lack of dopamine)
Describe the porcess of Synthesis of Catecholamines.
1) Tyrosine is converted to DOPA by tyrosine hydroxylase
2) DOPA is converted to dopamine via DOPA decarboxylase
3) Dopamine is then metabolised to noradrenaline via Dopamine-β hydroxylase
4) Noradrenaline can then further be metabolised to adrenaline